BF‑EssE at CPHI Frankfurt 2025 – Innovation, AI and New Partnerships
Last week the BF‑ESSE team was on the move — we attended CPHI Frankfurt 2025, one of the world’s largest gatherings for the pharmaceutical and nutraceutical supply chain. The show took place from 28‑30 October at Messe Frankfurt, and we returned with fresh insight, new connections, and a reaffirmed conviction: the future of supplement manufacturing is being defined right now.
Key Themes: AI, Digitalisation & Sustainability
As usual, artificial intelligence (AI) dominated the conversations on the floor. From sessions such as “AI Disruption in Pharma – From Hype to Real Impact” to panel discussions on digital tools and data‑driven manufacturing, it’s clear: for contract manufacturers, ingredient suppliers and private label brands alike, embracing digitalisation is no longer optional.
One report called AI the “second wave of renaissance” for CDMO and manufacturing partners — a game‑changer in quality‑control, deviation detection and process optimisation.
Other major themes included sustainability and supply chain resilience — new zones at CPHI emphasised “Sustainable Futures” and “Packaging & Device Innovation”, highlighting how eco‑friendly materials and smart packaging are becoming critical in the nutraceutical world too.
Key Themes: AI, Digitalisation & Sustainability
As usual, artificial intelligence (AI) dominated the conversations on the floor. From sessions such as “AI Disruption in Pharma – From Hype to Real Impact” to panel discussions on digital tools and data‑driven manufacturing, it’s clear: for contract manufacturers, ingredient suppliers and private label brands alike, embracing digitalisation is no longer optional.
One report called AI the “second wave of renaissance” for CDMO and manufacturing partners — a game‑changer in quality‑control, deviation detection and process optimisation.
Other major themes included sustainability and supply chain resilience — new zones at CPHI emphasised “Sustainable Futures” and “Packaging & Device Innovation”, highlighting how eco‑friendly materials and smart packaging are becoming critical in the nutraceutical world too.
BF-EssE Team at CPHI 2025
At BF‑EssE we focus on nutraceutical and supplement manufacturing, private label, and contract development. On the CPHI floor we saw that many traditional CDMO/CMO players are now talking the same language we are: collagen, custom formulations, private label supply. Yet it’s the technological layer — AI, real‑time analytics, digital R&D platforms — that distinguishes the frontrunners.
We met new potential partners, strengthened relationships with long‑time collaborators and learned fresh lessons. Here are a few highlights:
We met new potential partners, strengthened relationships with long‑time collaborators and learned fresh lessons. Here are a few highlights:
- Role of AI and Big Data for Analytics: Companies emphasised how omics data and digitised manufacturing processes (driven by machine learning) are now enabling faster development and lower costs.
- Supply chain and ingredients innovation: The session on excipients and formulation challenges drew attention to how supplement manufacturers must anticipate regulatory and sourcing pressures.
- Private label and contract manufacturing convergence: We found more crossover between pharma‑style CDMO services and nutraceutical contract manufacturing, confirming our belief that BF‑EssE’s hybrid model (supplements + ingredient expertise) is well‑positioned for the next wave.
What We Observed
BF-EssE team during the CPHI in Frankfurt 2025
Why It Matters for BF‑EssE
For us, CPHI isn’t just an exhibition — it’s a strategic barometer. Attending confirms where the market is going, and shapes how we serve our customers. Here’s how:
- Innovation in product development: The push toward smart manufacturing and data‑driven results reinforces our focus on high‑value ingredients like collagen, gender‑specific formulations (women/men), and next‑generation supplement delivery systems.
- Enhanced service offer: Meeting new partners and seeing emerging technologies expands our capability set — from AI‑assisted formulation to digital R&D workflows, BF‑ESSE can now incorporate more advanced services for private label brands.
- Stronger industry network: Reconnecting with existing collaborators and building new links ensures we remain an agile partner for brands exploring Europe and global markets.
- Clear market signals: The convergence of sustainability, authenticity and tech means that brands working with us will not only ‘get their product made’, but also be equipped for future‑proof positioning.
What’s Next
Following CPHI Frankfurt 2025, our next steps at BF‑ESSE include:
- Integrating new insights from AI and digital manufacturing into our “Solutions” content‑hub, so clients can access practical analysis on collagen, gender‑targets (women/men), private label development and ingredient innovation.
- Exploring targeted collaboration with partners we met in Frankfurt — to bring cutting‑edge technologies into our pipeline.
- Strengthening our network of brand‑owners, retailers and ingredient suppliers across Europe — particularly in the nutraceutical and supplement space.
- Publishing reflections and key‑take‑aways from the show in our blog, so clients see how we’re applying what we learn in real time.
What’s Next
Final ThoughtsAttending CPHI Frankfurt this year confirmed for us: the future of nutraceutical manufacturing is one of smart, transparent, sustainable and tech‑enabled service. AI is not just a buzzword — it’s becoming the backbone of how contract manufacturing and private label are managed.
At BF‑EssE, we’re not just responding to that future — we’re building for it. As always, our goal is to provide real solutions for brand‑owners, not just talk about them.
At BF‑EssE, we’re not just responding to that future — we’re building for it. As always, our goal is to provide real solutions for brand‑owners, not just talk about them.
We welcome any brand or entrepreneur who wants to explore how advanced manufacturing, high‑value ingredients and forward‑looking strategy come together. Connect with us and let’s build the next generation of supplements — together.